ClinicalTrials.Veeva

Menu

Maximal Rate of Force Development of Ankle Muscles and Functional Ability in Patients With Knee Osteoarthritis

A

Ahram Canadian University

Status

Completed

Conditions

Knee Arthritis
Knee Osteoarthritis

Treatments

Diagnostic Test: Maximal Rate of Force Development Test for Ankle Muscles

Study type

Observational

Funder types

Other

Identifiers

NCT06063889
012/90002023

Details and patient eligibility

About

This study is a detailed assessment of the maximal rate of force development of ankle muscles and its association with functional ability in patients with knee osteoarthritis (OA).

Full description

This research is designed to study the link between force development in ankle muscles and functional abilities in knee OA patients. It aims to understand the influence of ankle muscle strength, specifically plantar flexors, on the stability, pain, and functionality of patients with knee OA. The study will analyze the rate of force development, its importance in explosive strength improvement, and impact on preventing knee injuries. Furthermore, it will investigate the compensatory mechanism of the plantar flexors developed by patients in advanced stages to balance other muscle failures.

Enrollment

126 patients

Sex

All

Ages

30 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Group 1 (Knee OA group)

    1. Patients diagnosed with knee osteoarthritis according to Performance of the 2018 classification criteria for early stage knee OA was tested using data from the Osteoarthritis Initiative (OAI (Leung et al.,2020).
    2. Grade 2-3 KOA cases according to Kelgren-Lawrance classification
    3. Having knee pain for at least 6 months.
    4. The visual analog scale (VAS) score being at least 3 or more.
  • Group 2 (Healthy control group) 1. Individuals with no signs or symptoms of Knee OA or other neurological or musculoskeletal conditions.

Exclusion criteria

  1. Patellar subluxation
  2. Surgery in any joint of the lower limb
  3. Meniscal injury
  4. Ligament instability
  5. Patients who received intra-articular injection in the knee in the last 6 months
  6. Patients with problems in the hip and ankle
  7. Patients who participated in in another physical therapy program in the last 3 months were not included in the study.

Trial design

126 participants in 2 patient groups

Knee OA Patients
Description:
This group consists of patients who have been diagnosed with knee osteoarthritis. They will be subjected to a series of tests to assess the maximal rate of force development of ankle muscles and their functional abilities.
Treatment:
Diagnostic Test: Maximal Rate of Force Development Test for Ankle Muscles
Healthy Control
Description:
This group will include healthy individuals without knee osteoarthritis. They will undergo the same series of tests to serve as a control group, enabling the comparison of results with the Knee OA Patients group.
Treatment:
Diagnostic Test: Maximal Rate of Force Development Test for Ankle Muscles

Trial contacts and locations

1

Loading...

Central trial contact

Mohamed ElMeligie, Ph.D; AYA KHALIL, Ph.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems